SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    De Angelis CD, Drazen JM, Frizelle FA, Haug C, Hoey J, Horton R, et al. Clinical trial registration: a statement from the International Committee of Medical Journal Editors. JAMA 2004; 292: 13634.
  • 2
    The Ottawa Statement, part one: principles for international registration of protocol information and results from human trials of health-related interventions. URL: http://ottawagroup.ohri.ca/statement.html.
  • 3
    Fair Access to Clinical Trials Act of 2004, H.R. 5252, 108th Congress, 2d Session.
  • 4
    Whittington CJ, Kendall T, Fonagy P, Cottrell D, Cotgrove A, Boddington E. Selective serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished data [review]. Lancet 2004; 363: 13415.
  • 5
    Is GSK guilty of fraud? Lancet 2004;363: 1919.
  • 6
    Topol EJ. Failing the public health: rofecoxib, Merck, and the FDA. N Engl J Med 2004; 351: 17079.
  • 7
    Topol EJ. Arthritis medicines and cardiovascular events: “house of coxibs. ” JAMA 2005; 293: 3668.
  • 8
    De Angelis CD, Drazen JM, Frizelle FA, Haug C, Hoey J, Horton R, et al. Is this clinical trial fully registered? A statement from the International Committee of Medical Journal Editors. N Engl J Med 2005; 352: 24368.